Found: 12
Select item for more details and to access through your institution.
Annamycin circumvents resistance mediated by the multidrug resistance-associated protein (MRP) in breast MCF-7 and small-cell lung UMCC-1 cancer cell lines selected for resistance to etoposide.
- Published in:
- International Journal of Cancer, 1997, v. 71, n. 1, p. 35, doi. 10.1002/(SICI)1097-0215(19970328)71:1<35::AID-IJC8>3.0.CO;2-4
- By:
- Publication type:
- Article
Characterization of a 95 kilodalton membrane glycoprotein associated with multi-drug resistance.
- Published in:
- International Journal of Cancer, 1995, v. 62, n. 5, p. 593, doi. 10.1002/ijc.2910620517
- By:
- Publication type:
- Article
Erythema and Desquamation After High-Dose Methotrexate.
- Published in:
- Annals of Internal Medicine, 1983, v. 98, n. 5, p. 611, doi. 10.7326/0003-4819-98-5-611
- By:
- Publication type:
- Article
Phase I study of cediranib, an oral VEGFR inhibitor, in combination with selumetinib, an oral MEK inhibitor, in patients with advanced solid malignancies.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 1, p. 115, doi. 10.1007/s10637-021-01175-6
- By:
- Publication type:
- Article
A Phase II Trial of the Epothilone B Analog Ixabepilone (BMS-247550) in Patients with Metastatic Melanoma.
- Published in:
- PLoS ONE, 2010, v. 5, n. 1, p. 1, doi. 10.1371/journal.pone.0008714
- By:
- Publication type:
- Article
Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines.
- Published in:
- 1999
- By:
- Publication type:
- journal article
Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).
- Published in:
- Oncogene, 2003, v. 22, n. 47, p. 7340, doi. 10.1038/sj.onc.1206938
- By:
- Publication type:
- Article
Phase I study of docetaxel and topotecan in patients with solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2000, v. 46, n. 6, p. 442, doi. 10.1007/s002800000180
- By:
- Publication type:
- Article
Phase II study of cixutumumab in combination with temsirolimus in pediatric patients and young adults with recurrent or refractory sarcoma: A report from the children's oncology group.
- Published in:
- Pediatric Blood & Cancer, 2015, v. 62, n. 3, p. 440, doi. 10.1002/pbc.25334
- By:
- Publication type:
- Article
A phase I trial of MK-2206 in children with refractory malignancies: A Children's Oncology Group study.
- Published in:
- Pediatric Blood & Cancer, 2014, v. 61, n. 7, p. 1246, doi. 10.1002/pbc.25023
- By:
- Publication type:
- Article
A Phase I Study of Dinaciclib in Combination With MK‐2206 in Patients With Advanced Pancreatic Cancer.
- Published in:
- CTS: Clinical & Translational Science, 2020, v. 13, n. 6, p. 1178, doi. 10.1111/cts.12802
- By:
- Publication type:
- Article
Corrigendum to: LTBK-01. Updates On The Phase Ii And Re-treatment Study Of AZD6244 (Selumetinib) For Children With Recurrent Or Refractory Pediatric Low Grade Glioma: A Pediatric Brain Tumor Consortium (PBTC) Study.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 8, p. 1404, doi. 10.1093/neuonc/noac029
- By:
- Publication type:
- Article